Clinical use of interferon
Jakó, J.
Orvosi Hetilap 132(36): 2010
1991
ISSN/ISBN: 0030-6002 PMID: 1717919 Document Number: 381275
Document emailed within 1 workday
Related Documents
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Sinkovics, J.G. 1991: Clinical use of interferon Orvosi Hetilap 132(37): 2065
Zamorska, I.; Kozłowski, M. 1990: Interferon--clinical application Wiadomosci Lekarskie 43(11): 548-551
Nosik, N.N.; Ershov, F.I. 1980: Clinical use of interferon and its inducers Antibiotiki 25(9): 695-710
Bektemirov, T.A.; Shul'tsev, G.P. 1973: Interferon, its clinical significance and use Terapevticheskii Arkhiv 45(1): 10-15
Flury, F.; Wegmann, T. 1979: Clinical experiences with the interferon therapy Schweizerische Rundschau für Medizin Praxis 68(43): 1401-1405
Shishido, A.; Kohno, S. 1977: Problems of clinical application of interferon Nihon Rinsho. Japanese Journal of Clinical Medicine 35(9): 2832-2837
Imanishi, J.; Kishida, T. 1981: Clinical trials with interferon in Japan Texas Reports on Biology and Medicine 41: 647-652
Ogawa, M. 1983: Current status of clinical studies of interferon Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(7): 1717-1721
Petricciani, J.; Esber, E.; Attallah, A.; Hopps, H. 1981: Safety considerations for interferon used in clinical research Texas Reports on Biology and Medicine 41: 289-293
Vermersch, P. 1999: Interferon beta-1a (Avonex TM): clinical and MRI impacts Revue Neurologique (Paris) 155(Suppl 2): S13-S19
Sekiya, S.; Iwasawa, H.; Ishige, H.; Takamizawa, H. 1985: Clinical trial of interferon in gynecologic cancers Nihon Sanka Fujinka Gakkai Zasshi 37(7): 1241-1243
Cheung, R.C.; Keeffe, E.B. 1997: Hepatitis G virus: clinical relevance and responsiveness to interferon American Journal of Gastroenterology 92(11): 1957-1959
Tilz, G.P.; Lanzer, G. 1980: Immunotherapy II: clinical investigations for the induction and activity of interferon Acta Medica Austriaca 7(3): 77-79
Ringenberg, Q.S.; Patterson, W.P. 1988: Clinical uses for interferon in the treatment of cancer. a critical review Missouri Medicine 85(1): 21-26
Günther, G.; Otto, B. 1993: Interferon. An overview of the state of basic research with special regard to interferon-gamma Arzneimittel-Forschung 43(2): 182-188
Akimoto, M.; Ueki, H.; Nakajima, Y.; Matano, S.; Ewasaki, H.; Abe, R.; Kasai, M. 1984: Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(7): 1462-1467
Lvovsky, E.A.; D'Souza, J.; Eng, D.; D'Souza, D.; Lvovsky, B.; Hetland, R.; Craver, W.L.; Sobel, S.H. 1988: Tumor response to interferon inducer and radiation effect of serum interferon levels Journal of Biological Regulators and Homeostatic Agents 2(1): 1-6
Sumpio, B.E.; Ernstoff, M.S.; Kirkwood, J.M. 1984: Urinary excretion of interferon, albumin, and beta 2-microglobulin during interferon treatment Cancer Research 44(8): 3599-3603